𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advancing Therapy For Chronic Lymphocytic Leukemia–the Role Of Rituximab

✍ Scribed by Peter Hillmen

Book ID
114473437
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
141 KB
Volume
31
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab therapy for chronic lymphocyti
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
✍ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W